HIV mutation literature information.


  Drug Resistance to HIV-1 Integrase Inhibitors Among Treatment-Naive Patients in Beijing, China.
 PMID: 35300056       2022       Pharmacogenomics and personalized medicine
Result: M184V (0.23%, 2/865) was the most common nucleoside reverse transcriptase inhibitors (NRTIs) related mutation followed by T69D (0.12%, 1/865) and T69G (0.12%, 1/865).


  Prevalence of HIV-1 drug resistance in Eastern European and Central Asian countries.
 PMID: 35061671       2022       PloS one
Result: T69D and L210W were also found in Armenia (3/120; 2.5%).
Table: T69D
Discussion: Common NRTI DRMs included polymorphic mutations for sub-subtype A6, including A62V, M41L and L210W, which are associated with low levels of DR to AZT, and T69D, which has a minimal effect on susceptibility to drugs.


  Emergence of Resistance in HIV-1 Integrase with Dolutegravir Treatment in a Pediatric Population from the IMPAACT P1093 Study.
 PMID: 34694878       2022       Antimicrobial agents and chemotherapy
Table: T69A/D


  High HIV-1 Virological Failure and Drug Resistance among Adult Patients Receiving First-Line ART for At least 12 Months at a Decentralized Urban HIV Clinic Setting in Senegal before the Test-and-Treat.
 PMID: 34025122       2021       Infectious diseases
Result: Nonetheless, in patient 279A K70R co-occurred with K219E, the TAM variant D67G, and T69D, suggesting undisclosed use of AZT (http://hivdb.stanford.edu).
Table: T69D


  Increase in HIV-1-transmitted drug resistance among ART-naive youths at the China-Myanmar border during 2009 ~ 2017.
 PMID: 33478415       2021       BMC infectious diseases
Table: T69D


  Correlation of HIV-1 drug resistant mutations and virologic failure.
 PMID: 34584606       2021       The Pan African medical journal
Abstract: Out of 17 new mutations, 14 resulted in virologic failure and included NRTIs (L74I, L74V, T69D, V65R); NNRTIs (A98G, V179E, V179F, V179D, 179F); PIs (I54V3, F53L2, L89T, G48A).
Result: Most of the new mutations also encoded for resistance to prescribed drugs and these included L74I/V, T69D, V65R as NRTIs; A98G,  PMID: 34959542       2021       Pathogens (Basel, Switzerland)
Result: Other interesting clusters evidencing PDR transmission within the network included cluster PI-1, with 29 nodes, all men with PI resistance and median age 24 (22-28) enrolled across all years; cluster NRTI-1, with 23 nodes, 22 cisgender men and 1 cisgender woman, with median age 22 (10-27) and constant growth across all years; cluster complex-1, with 10 nodes, all men enrolled from 2018 to 2020 and median age 23 (20-30), 60% (6/10) with PI + NRTI + NNRTI resistance and 40% (4/10) with PI + NRTI resistance; and complex-2, with 7 nodes, all men with median age 26 (21-31) sharing PR M46I, L90M,


  High prevalence of integrase mutation L74I in West African HIV-1 subtypes prior to integrase inhibitor treatment.
 PMID: 32105319       2020       The Journal of antimicrobial chemotherapy
Table: T69D


  Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda.
 PMID: 32005262       2020       AIDS research and therapy
Result: On the other hand, the least frequent NRTI mutations were F77L that occurred in 2 (1.1%) of the patients followed by Q151M and T69D at 3 (1.6%).


  Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China.
 PMID: 32183889       2020       Virology journal
Table: T69S/D



Browser Board

 Co-occurred Entities




   Filtrator